Aeterna Zentaris (AEZS +1.8%) gains after saying it's signed an exclusive agreement for the registration and marketing of perifosine in the Middle East and North Africa with Hikma Pharmaceuticals (HKMPY.PK).
Aeterna Zentaris (AEZS +1.8%) gains after saying it's signed an exclusive agreement for the...
From other sites
at CNBC.com (Nov 6, 2014)
at CNBC.com (Jan 9, 2013)
at CNBC.com (Mar 6, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs